SFRP4 and myocardial ischemia: reported that SFRP4 knockdown activated the PI3K/AKT pathway, thereby reducing cardiomyocyte apoptosis, decreasing infarct size, and improving cardiac function following myocardial ischemia/reperfusion injury [267].